| 000 | 01905 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518090129.0 | ||
| 264 | 0 | _c20210429 | |
| 008 | 202104s 0 0 eng d | ||
| 022 | _a1582-4934 | ||
| 024 | 7 |
_a10.1111/jcmm.15090 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhou, Xiao-Tian | |
| 245 | 0 | 0 |
_aHedgehog signalling mediates drug resistance through targeting TAP1 in hepatocellular carcinoma. _h[electronic resource] |
| 260 |
_bJournal of cellular and molecular medicine _c04 2020 |
||
| 300 |
_a4298-4311 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 2 _xgenetics |
| 650 | 0 | 4 |
_aCarcinogenesis _xdrug effects |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 |
_aHedgehog Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNuclear Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aZinc Finger Protein GLI1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aZinc Finger Protein Gli2 _xantagonists & inhibitors |
| 700 | 1 | _aDing, Jia | |
| 700 | 1 | _aLi, Hui-Yan | |
| 700 | 1 | _aZuo, Jie-Liang | |
| 700 | 1 | _aGe, Sheng-Yang | |
| 700 | 1 | _aJia, Hu-Liang | |
| 700 | 1 | _aWu, Jian | |
| 773 | 0 |
_tJournal of cellular and molecular medicine _gvol. 24 _gno. 7 _gp. 4298-4311 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jcmm.15090 _zAvailable from publisher's website |
| 999 |
_c30683463 _d30683463 |
||